Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Molecular Biology [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
IBD4 [NCBI] 0.00101245
IBD6 [NCBI] 0.000912577
MYP3 [NCBI] 0.000847798
gout susceptibility 1 [NCBI] 0.000847798
autoimmune thyroid disease, susceptibility to, 1 [NCBI] 0.000847798
beta-aminoisobutyric acid, urinary excretion of [NCBI] 0.000729587
strabismus, susceptibility to [NCBI] 0.000702392
IBD5 [NCBI] 0.000638637
MYP2 [NCBI] 0.000591215
small cell cancer of the lung [NCBI] 0.000522215
ST3 [NCBI] 0.00050399
hashimoto thyroiditis [NCBI] 0.00049552
restless legs syndrome, susceptibility to, 1 [NCBI] 0.000472259
RA [NCBI] 0.00032622
APC [NCBI] 0.000240368
SLE [NCBI] 0.000188176
gout, hprt-related [NCBI] 0.000181171
corticosteroid-binding globulin deficiency [NCBI] 0.000153238
GRA [NCBI] 0.000148645
PGD [NCBI] 0.000131346
phosphatase, acid, of tissues [NCBI] 0.000124165
blood group--en [NCBI] 0.000124165
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency [NCBI] 0.000120419
HBB [NCBI] 0.000109976
VHL [NCBI] 0.000106849
HBD [NCBI] 9.73032e-05
lithium transport [NCBI] 9.64321e-05
favism, susceptibility to [NCBI] 9.64321e-05
GLC1A [NCBI] 9.29443e-05
HBA1 [NCBI] 8.77867e-05
G6PD [NCBI] 8.61582e-05
LNS [NCBI] 8.37608e-05
HPRT1 [NCBI] 7.62435e-05
STL3 [NCBI] 7.42011e-05
cystinosis, adult nonnephropathic [NCBI] 7.42011e-05
vohwinkel syndrome, variant form [NCBI] 7.42011e-05
eunuchoidism, familial hypogonadotropic [NCBI] 7.42011e-05
methylmalonic aciduria, cbla type [NCBI] 7.02076e-05
peroxidase and phospholipid deficiency in eosinophils [NCBI] 7.02076e-05
HDL1 [NCBI] 7.02076e-05
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain [NCBI] 7.02076e-05
pancreatic cancer, susceptibility to, 1 [NCBI] 6.68936e-05
deafness, congenital, with keratopachydermia and constrictions of fingers and toes [NCBI] 6.68936e-05
LSFC [NCBI] 6.68936e-05
GPI [NCBI] 6.59393e-05
pseudo-von willebrand disease [NCBI] 6.40623e-05
RP [NCBI] 6.36356e-05
HMN2A [NCBI] 6.15921e-05
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative [NCBI] 6.15921e-05
CMT2D [NCBI] 6.15921e-05
CMH4 [NCBI] 6.15921e-05
AK1 [NCBI] 6.02296e-05
SPG17 [NCBI] 5.94021e-05
keratitis-ichthyosis-deafness syndrome, autosomal dominant [NCBI] 5.94021e-05
FFI [NCBI] 5.86654e-05
SCA1 [NCBI] 5.78845e-05
scheie syndrome [NCBI] 5.74359e-05
galactokinase deficiency [NCBI] 5.74359e-05
MCDC1 [NCBI] 5.56528e-05
EGF [NCBI] 5.43303e-05
argininosuccinic aciduria [NCBI] 5.40219e-05
HMN5 [NCBI] 5.25199e-05
WGN1 [NCBI] 5.25199e-05
mucolipidosis iiia [NCBI] 5.25199e-05
NFNS [NCBI] 5.25199e-05
hypoascorbemia [NCBI] 5.25199e-05
TBG [NCBI] 5.19381e-05
CF [NCBI] 4.99103e-05
lecithin:cholesterol acyltransferase deficiency [NCBI] 4.98324e-05
PEPC [NCBI] 4.88975e-05
crigler-najjar syndrome [NCBI] 4.86201e-05
dopamine beta-hydroxylase deficiency, congenital [NCBI] 4.86201e-05
mucopolysaccharidosis type iiia [NCBI] 4.86201e-05
DHRD [NCBI] 4.86201e-05
GOT2 [NCBI] 4.77672e-05
ESCS [NCBI] 4.64086e-05
HEPOD [NCBI] 4.53943e-05
PARK8 [NCBI] 4.53943e-05
KTCN1 [NCBI] 4.53943e-05
FGA [NCBI] 4.49387e-05
GLC3A [NCBI] 4.44329e-05
gm1-gangliosidosis, type i [NCBI] 4.44329e-05
LDHC [NCBI] 4.4098e-05
ulcerative colitis, susceptibility to [NCBI] 4.35192e-05
CNC1 [NCBI] 4.35192e-05
MLC [NCBI] 4.26488e-05
EKV [NCBI] 4.26488e-05
DRD [NCBI] 4.26488e-05
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency [NCBI] 4.26488e-05
CBP [NCBI] 4.19476e-05
DRPLA [NCBI] 4.18802e-05
AMY1A [NCBI] 4.07072e-05
SMA2 [NCBI] 4.02629e-05
HNFJ [NCBI] 4.02629e-05
ZPBP2 [NCBI] 3.99209e-05
HBFQTL1 [NCBI] 3.95328e-05
CYP1B1 [NCBI] 3.90646e-05
PJS [NCBI] 3.90328e-05
AIMAH [NCBI] 3.88313e-05
LDHA [NCBI] 3.85651e-05
STL1 [NCBI] 3.7506e-05
ESD [NCBI] 3.59599e-05
LGMD2A [NCBI] 3.56875e-05
ATXN1 [NCBI] 3.5569e-05
glycogen storage disease ixa [NCBI] 3.51983e-05
FCAS [NCBI] 3.45723e-05
drug metabolism, poor, cyp2d6-related [NCBI] 3.45723e-05
SMA3 [NCBI] 3.40405e-05
CLN3 [NCBI] 3.40405e-05
MEB [NCBI] 3.40405e-05
lactase persistence [NCBI] 3.35246e-05
ATS [NCBI] 3.35246e-05
ACP1 [NCBI] 3.35064e-05
CTNS [NCBI] 3.30238e-05
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity [NCBI] 3.30238e-05
OPTN [NCBI] 3.28943e-05
ZPBP [NCBI] 3.16805e-05
DOM3Z [NCBI] 3.16805e-05
hemophilia a [NCBI] 3.08884e-05
SCIDX1 [NCBI] 2.98795e-05
isoniazid inactivation [NCBI] 2.95645e-05
galactosemia [NCBI] 2.86944e-05
BRRS [NCBI] 2.86944e-05
MFS [NCBI] 2.86294e-05
NXT1 [NCBI] 2.85747e-05
PGM1 [NCBI] 2.8508e-05
C3 [NCBI] 2.8508e-05
FCMD [NCBI] 2.79495e-05
CCM [NCBI] 2.79495e-05
MJD [NCBI] 2.72691e-05
SYNGR1 [NCBI] 2.65604e-05
hurler syndrome [NCBI] 2.65553e-05
bare lymphocyte syndrome, type ii [NCBI] 2.6225e-05
HP [NCBI] 2.59788e-05
LQT1 [NCBI] 2.55843e-05
HOS [NCBI] 2.52735e-05
PTGER1 [NCBI] 2.50644e-05
STX16 [NCBI] 2.50644e-05
STE [NCBI] 2.50644e-05
RDT [NCBI] 2.49688e-05
IDUA [NCBI] 2.44998e-05
VRNI [NCBI] 2.44503e-05
CJD [NCBI] 2.41743e-05
NF1 [NCBI] 2.36233e-05
ND [NCBI] 2.35291e-05
SOD1 [NCBI] 2.3216e-05
HLA-A [NCBI] 2.31868e-05
MDH2 [NCBI] 2.28847e-05
BWS [NCBI] 2.24099e-05
PI [NCBI] 2.23811e-05
ACP2 [NCBI] 2.20391e-05
PTGIR [NCBI] 2.20391e-05
GNAT2 [NCBI] 2.20391e-05
IBD1 [NCBI] 2.19644e-05
BCHE [NCBI] 2.13408e-05
GNAL [NCBI] 2.13007e-05
FGF14 [NCBI] 2.13007e-05
MYOC [NCBI] 2.11691e-05
SMA1 [NCBI] 2.0776e-05
SULT1A3 [NCBI] 2.06456e-05
HBE1 [NCBI] 2.06456e-05
PTGER2 [NCBI] 2.06456e-05
EYA2 [NCBI] 2.06456e-05
ITIH1 [NCBI] 2.06456e-05
SORD [NCBI] 2.00569e-05
BLM [NCBI] 1.9891e-05
PKD1 [NCBI] 1.98323e-05
WRN [NCBI] 1.96781e-05
PTGER4 [NCBI] 1.95225e-05
von willebrand disease [NCBI] 1.93089e-05
TNF [NCBI] 1.92847e-05
HBA2 [NCBI] 1.9057e-05
MAS [NCBI] 1.86596e-05
LDLRAP1 [NCBI] 1.85825e-05
SRA2 [NCBI] 1.85825e-05
UBB [NCBI] 1.85825e-05
3-@hydroxy-3-methylglutaryl-coa lyase deficiency [NCBI] 1.81644e-05
PFKL [NCBI] 1.81644e-05
FUT1 [NCBI] 1.81644e-05
polycystic kidneys [NCBI] 1.78663e-05
PON1 [NCBI] 1.78112e-05
POMT1 [NCBI] 1.77748e-05
COCH [NCBI] 1.77748e-05
MYBPC3 [NCBI] 1.77748e-05
fabry disease [NCBI] 1.77115e-05
COL18A1 [NCBI] 1.74099e-05
NPHS1 [NCBI] 1.74099e-05
CYBA [NCBI] 1.74099e-05
CD [NCBI] 1.7173e-05
ALDOA [NCBI] 1.67436e-05
SPR [NCBI] 1.64375e-05
phenylketonuria ii [NCBI] 1.61472e-05
CLN3 [NCBI] 1.5871e-05
OR1D2 [NCBI] 1.56077e-05
NPY [NCBI] 1.54008e-05
CMH [NCBI] 1.53698e-05
hypercholesterolemia, autosomal dominant [NCBI] 1.53698e-05
TK1 [NCBI] 1.51155e-05
SLC3A1 [NCBI] 1.48847e-05
GLO1 [NCBI] 1.46631e-05
ATXN8OS [NCBI] 1.44499e-05
POLR2A [NCBI] 1.42446e-05
TIMP3 [NCBI] 1.42446e-05
CYP11B2 [NCBI] 1.36709e-05
DST [NCBI] 1.36709e-05
COL4A5 [NCBI] 1.36709e-05
BBS [NCBI] 1.35287e-05
KSS [NCBI] 1.35287e-05
KCNH2 [NCBI] 1.34749e-05
RECQL3 [NCBI] 1.33191e-05
DNAJC5 [NCBI] 1.31513e-05
ALB [NCBI] 1.30776e-05
CBD [NCBI] 1.29886e-05
PCD [NCBI] 1.28904e-05
ABCC6 [NCBI] 1.2677e-05
glycogen storage disease i [NCBI] 1.25276e-05
ABO [NCBI] 1.23823e-05
NOD2 [NCBI] 1.22408e-05
KLK3 [NCBI] 1.2138e-05
SMN2 [NCBI] 1.21029e-05
FY [NCBI] 1.21029e-05
HSCR1 [NCBI] 1.20533e-05
protoporphyria, erythropoietic [NCBI] 1.19685e-05
ADA [NCBI] 1.18951e-05
TFR2 [NCBI] 1.18374e-05
FGFR3 [NCBI] 1.17628e-05
BRAF [NCBI] 1.17094e-05
REST [NCBI] 1.14623e-05
GSR [NCBI] 1.14623e-05
methemoglobinemia due to deficiency of methemoglobin reductase [NCBI] 1.12262e-05
AKT1 [NCBI] 1.10003e-05
SMAX1 [NCBI] 1.09592e-05
factor vii deficiency [NCBI] 1.08909e-05
PRL [NCBI] 1.08818e-05
HS [NCBI] 1.07837e-05
PXE [NCBI] 1.07535e-05
CFB [NCBI] 1.06787e-05
GALT [NCBI] 1.05758e-05
MSH2 [NCBI] 1.03758e-05
MYH7 [NCBI] 1.03758e-05
NAT1 [NCBI] 1.01833e-05
KCNQ1 [NCBI] 9.90754e-06
PGK1 [NCBI] 9.90754e-06
CEACAM1 [NCBI] 9.6459e-06
UGT1A1 [NCBI] 9.56161e-06
CRC [NCBI] 9.38622e-06
GPT [NCBI] 9.31691e-06
AQP2 [NCBI] 9.08362e-06
DRD4 [NCBI] 8.93397e-06
MC4R [NCBI] 8.93397e-06
DFSP [NCBI] 8.73544e-06
SLOS [NCBI] 8.73544e-06
WBS [NCBI] 8.73544e-06
TTR [NCBI] 8.67915e-06
STAT6 [NCBI] 8.18391e-06
MTHFR [NCBI] 8.18391e-06
VHL [NCBI] 7.99808e-06
DGS [NCBI] 7.8715e-06
ichthyosis, x-linked [NCBI] 7.7037e-06
APOE [NCBI] 7.68129e-06
SMN1 [NCBI] 7.64697e-06
leber optic atrophy [NCBI] 7.5061e-06
CEACAM5 [NCBI] 7.48855e-06
LMNA [NCBI] 7.11489e-06
EGFR [NCBI] 6.96178e-06
VIP [NCBI] 6.94639e-06
GIST [NCBI] 6.43853e-06
AD [NCBI] 6.09621e-06
MAPT [NCBI] 6.08766e-06
VEGF [NCBI] 5.71558e-06
INSR [NCBI] 5.67129e-06
OMP [NCBI] 5.63542e-06
TBP [NCBI] 5.46066e-06
GC [NCBI] 5.22803e-06
HMBS [NCBI] 5.19587e-06
ABCB1 [NCBI] 5.16398e-06
ACHE [NCBI] 4.70215e-06
apc gene [NCBI] 4.52166e-06
AFP [NCBI] 4.4613e-06
APP [NCBI] 4.38983e-06
TH [NCBI] 4.38836e-06
AVP [NCBI] 4.31092e-06
HEMB [NCBI] 4.2377e-06
ALK [NCBI] 3.73036e-06
FAAH [NCBI] 3.64576e-06
PRNP [NCBI] 3.58371e-06
COMT [NCBI] 3.50289e-06
FMR1 [NCBI] 3.42384e-06
phenylketonuria [NCBI] 3.2903e-06
GFAP [NCBI] 3.24078e-06
FRAP1 [NCBI] 3.0581e-06
WAS [NCBI] 2.99765e-06
CAT [NCBI] 2.93942e-06
SERPINA6 [NCBI] 2.74569e-06
LPL [NCBI] 2.51946e-06
GAPDH [NCBI] 2.25582e-06
BDNF [NCBI] 2.22678e-06
CP [NCBI] 1.92941e-06
GTS [NCBI] 1.77706e-06
LCAT [NCBI] 1.76854e-06
LDLR [NCBI] 1.75824e-06
PTH [NCBI] 1.59141e-06
TPO [NCBI] 1.54424e-06
ALD [NCBI] 1.40681e-06
GHRH [NCBI] 1.25607e-06
TYMS [NCBI] 1.12921e-06
DHFR [NCBI] 9.66778e-07
VDR [NCBI] 9.25633e-07
NPPA [NCBI] 9.22003e-07
MB [NCBI] 8.86387e-07
PWS [NCBI] 8.21507e-07
lymphoma, non-hodgkin, familial [NCBI] 7.53798e-07
ACE [NCBI] 7.45768e-07
CTGF [NCBI] 5.76345e-07
CRH [NCBI] 2.67322e-07
TS [NCBI] 2.34267e-07
TG [NCBI] 2.18361e-07
XDH [NCBI] 5.50574e-08
FMF [NCBI] 3.65224e-08
APOB [NCBI] 2.99494e-08
AR [NCBI] 2.23426e-08
CNTF [NCBI] 2.06535e-08
SLC6A3 [NCBI] 1.37048e-08
POMC [NCBI] 1.21992e-08
GNRH1 [NCBI] 2.46701e-09



Database Center for Life Science